NervGen Pharma Corp.
NGENF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17,267 | $11,660 | $22,452 | $16,929 |
| Short-Term Investments | $97 | $0 | $0 | $0 |
| Receivables | $97 | $250 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,551 | $606 | $670 | $428 |
| Total Curr. Assets | $19,013 | $12,515 | $23,149 | $17,420 |
| Property Plant & Equip (Net) | $0 | $200 | $295 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $465 | $521 | $431 | $473 |
| Long-Term Investments | $8 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | $0 |
| Total NC Assets | $473 | $721 | $727 | $476 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19,486 | $13,236 | $23,875 | $17,896 |
| Liabilities | – | – | – | – |
| Payables | $0 | $550 | $2,002 | $353 |
| Short-Term Debt | $97 | $92 | $86 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1,396 | $0 |
| Other Curr. Liab. | $16,804 | $14,498 | $8,129 | $726 |
| Total Curr. Liab. | $16,901 | $15,140 | $10,217 | $1,078 |
| LT Debt | $8 | $106 | $197 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $8 | $106 | $197 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $106 | $197 | $283 | $0 |
| Total Liabilities | $16,910 | $15,245 | $10,414 | $1,078 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $81,100 | $58,932 | $57,412 | $42,403 |
| Retained Earnings | -$102,159 | -$78,153 | -$55,771 | -$35,049 |
| AOCI | $23,636 | $17,212 | $11,820 | $9,464 |
| Other Equity | $0 | -$0 | $0 | $0 |
| Total Equity | $2,577 | -$2,009 | $13,461 | $16,818 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $19,486 | $13,236 | $23,875 | $17,896 |
| Net Debt | -$17,162 | -$11,462 | -$22,168 | -$16,929 |